Related references
Note: Only part of the references are listed.Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning
Vittorio Martinelli et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
MS disease activity in RESTORE A randomized 24-week natalizumab treatment interruption study
Robert J. Fox et al.
NEUROLOGY (2014)
Natalizumab Use During the Third trimester of Pregnancy
Aiden Haghikia et al.
JAMA NEUROLOGY (2014)
Natalizumab treatment during pregnancy - effects on the neonatal immune system
H. Schneider et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Joachim Havla et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2013)
Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Augusto Miravalle et al.
ARCHIVES OF NEUROLOGY (2011)
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment
Kerstin Hellwig et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis
P. W. O'Connor et al.
NEUROLOGY (2011)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse
S Vukusic et al.
BRAIN (2004)
Share Paper
